TOWNSEND RICHARD NOLAN (Chief Executive Officer) sold 2.5% of their position (10.17K shares) of LEXEO THERAPEUTICS, INC. on the open market
Open‑market sale worth $64.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/20/2026ACC: 0001995218-26-000004
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-10.17K
Net shares
Net seller
$64.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.17K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.17K
Price / share
$6.38
Trade value
$64.92K
% of position
2.5%
2/18/2026
402.66K→392.48K
Total
Net shares
−10.17K
Net value
-$64.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/18/2026 | S · Sale | −10.17K | $6.38 | $64.92K | 2.5% | 402.66K | 392.48K |
| Total | −10.17K | -$64.92K | ||||||
Derivative Transactions0
No derivative transactions reported